Distinct epigenetic mechanisms distinguish TMPRSS2-ERG fusion-positive and -negative prostate cancers

Joshi Alumkal, James G. Herman

    Research output: Contribution to journalArticle

    7 Citations (Scopus)

    Abstract

    This issue of Cancer Discovery features an article that describes distinct epigenetic mechanisms that operate in TMPRSS2-ERG fusion-negative prostate cancers. This finding clarifies molecular features of these TMPRSS2-ERG fusion-negative tumors and may have implications for how to treat this prostate cancer subtype.

    Original languageEnglish (US)
    Pages (from-to)979-981
    Number of pages3
    JournalCancer Discovery
    Volume2
    Issue number11
    DOIs
    StatePublished - Nov 2012

    Fingerprint

    Epigenomics
    Prostatic Neoplasms
    Neoplasms

    ASJC Scopus subject areas

    • Oncology

    Cite this

    Distinct epigenetic mechanisms distinguish TMPRSS2-ERG fusion-positive and -negative prostate cancers. / Alumkal, Joshi; Herman, James G.

    In: Cancer Discovery, Vol. 2, No. 11, 11.2012, p. 979-981.

    Research output: Contribution to journalArticle

    @article{a21b7a3904cf4ba1ba79ceef4b407aef,
    title = "Distinct epigenetic mechanisms distinguish TMPRSS2-ERG fusion-positive and -negative prostate cancers",
    abstract = "This issue of Cancer Discovery features an article that describes distinct epigenetic mechanisms that operate in TMPRSS2-ERG fusion-negative prostate cancers. This finding clarifies molecular features of these TMPRSS2-ERG fusion-negative tumors and may have implications for how to treat this prostate cancer subtype.",
    author = "Joshi Alumkal and Herman, {James G.}",
    year = "2012",
    month = "11",
    doi = "10.1158/2159-8290.CD-12-0392",
    language = "English (US)",
    volume = "2",
    pages = "979--981",
    journal = "Cancer Discovery",
    issn = "2159-8274",
    publisher = "American Association for Cancer Research Inc.",
    number = "11",

    }

    TY - JOUR

    T1 - Distinct epigenetic mechanisms distinguish TMPRSS2-ERG fusion-positive and -negative prostate cancers

    AU - Alumkal, Joshi

    AU - Herman, James G.

    PY - 2012/11

    Y1 - 2012/11

    N2 - This issue of Cancer Discovery features an article that describes distinct epigenetic mechanisms that operate in TMPRSS2-ERG fusion-negative prostate cancers. This finding clarifies molecular features of these TMPRSS2-ERG fusion-negative tumors and may have implications for how to treat this prostate cancer subtype.

    AB - This issue of Cancer Discovery features an article that describes distinct epigenetic mechanisms that operate in TMPRSS2-ERG fusion-negative prostate cancers. This finding clarifies molecular features of these TMPRSS2-ERG fusion-negative tumors and may have implications for how to treat this prostate cancer subtype.

    UR - http://www.scopus.com/inward/record.url?scp=84870003550&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84870003550&partnerID=8YFLogxK

    U2 - 10.1158/2159-8290.CD-12-0392

    DO - 10.1158/2159-8290.CD-12-0392

    M3 - Article

    C2 - 23148372

    AN - SCOPUS:84870003550

    VL - 2

    SP - 979

    EP - 981

    JO - Cancer Discovery

    JF - Cancer Discovery

    SN - 2159-8274

    IS - 11

    ER -